Breaking News

EDF Names Jean-Bernard Levy Interim Chairman, CEO

Elan Refused to Engage With Royalty Over Weekend, Chairman Says

Co. predicts “lengthy, and we think likely fruitless, effort to find a buyer willing to offer more than we are,” Royalty Pharma Chairman Rory Riggs says in letter today. * Elan has effectively been for sale for almost four months as a result of Royalty approach, Riggs says * If no buyer emerged in that time, it suggests none is interested at a price above Royalty’s offer, Riggs says.

To contact the reporter on this story: Makiko Kitamura in London at

To contact the editor responsible for this story: Phil Serafino at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.